Erythrocyte Na+-K+-ATPase Activity, Metabolic Control, and Neuropathy in IDDM Patients Diabetes Care June 1996 19:564-568; doi:10.2337/diacare.19.6.564
Effect of Follow-Up of Women With Gestational Diabetes on the Ratio of IDDM to NIDDM in Pregnancy Diabetes Care June 1996 19:653-655; doi:10.2337/diacare.19.6.653
American Diabetes Association Postgraduate Course, 1996: Monitoring Glucose, Defining Diabetes, and Treating Obesity Diabetes Care June 1996 19:676-679; doi:10.2337/diacare.19.6.676
Brechtel, Ginger
Glucose and Amino Acid Turnover in Untreated Gestational Diabetes Diabetes Care June 1996 19:591-596; doi:10.2337/diacare.19.6.591
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
Burchfiel, Cecil M
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
Glycemic Responses to Exercise in IDDM After Simple and Complex Carbohydrate Supplementation Diabetes Care June 1996 19:575-579; doi:10.2337/diacare.19.6.575
Glycemic Responses to Exercise in IDDM After Simple and Complex Carbohydrate Supplementation Diabetes Care June 1996 19:575-579; doi:10.2337/diacare.19.6.575
Bromocriptine (Ergoset) Reduces Body Weight and Improves Glucose Tolerance in Obese Subjects Diabetes Care June 1996 19:667-670; doi:10.2337/diacare.19.6.667
Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive
cases Diabetes Care June 1996 19:638-641; doi:10.2337/diacare.19.6.638
Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I
diabetic patients Diabetes Care June 1996 19:580-586; doi:10.2337/diacare.19.6.580
Spurious Ketonuria Due to Captopril and Other Free Sulfhydryl Drugs: Proposed changes in current guidelines for urine ketone
testing in diabetic patients Diabetes Care June 1996 19:673-674; doi:10.2337/diacare.19.6.673
Curb, Jess David
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
Effect of Follow-Up of Women With Gestational Diabetes on the Ratio of IDDM to NIDDM in Pregnancy Diabetes Care June 1996 19:653-655; doi:10.2337/diacare.19.6.653
Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience Diabetes Care June 1996 19:601-606; doi:10.2337/diacare.19.6.601
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
Denne, Scott C
Glucose and Amino Acid Turnover in Untreated Gestational Diabetes Diabetes Care June 1996 19:591-596; doi:10.2337/diacare.19.6.591
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
Spurious Ketonuria Due to Captopril and Other Free Sulfhydryl Drugs: Proposed changes in current guidelines for urine ketone
testing in diabetic patients Diabetes Care June 1996 19:673-674; doi:10.2337/diacare.19.6.673
F
Fabreguettes, Claudie
Erythrocyte Na+-K+-ATPase Activity, Metabolic Control, and Neuropathy in IDDM Patients Diabetes Care June 1996 19:564-568; doi:10.2337/diacare.19.6.564
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
Glycemic Responses to Exercise in IDDM After Simple and Complex Carbohydrate Supplementation Diabetes Care June 1996 19:575-579; doi:10.2337/diacare.19.6.575
Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive
cases Diabetes Care June 1996 19:638-641; doi:10.2337/diacare.19.6.638
Proinsulin Secretion During the First 3 Years After Diagnosis in Diabetic Patients With and Without Islet Cell Antibodies
Diabetes Care June 1996 19:659-662; doi:10.2337/diacare.19.6.659
Metformin Useful in Combination With Exogenous Insulin Diabetes Care June 1996 19:671-672; doi:10.2337/diacare.19.6.671b
Hara, Tomohiro
An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDM Diabetes Care June 1996 19:642-647; doi:10.2337/diacare.19.6.642
Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I
diabetic patients Diabetes Care June 1996 19:580-586; doi:10.2337/diacare.19.6.580
An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDM Diabetes Care June 1996 19:642-647; doi:10.2337/diacare.19.6.642
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
Jannasch, Karl
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
Jaruratanasirikui, Somchit
GAD Antibodies in IDDM in Thailand Diabetes Care June 1996 19:674-675; doi:10.2337/diacare.19.6.674
Jeffcoate, William J
Effect of Long-Term Glycemic Control on Cognitive Function Diabetes Care June 1996 19:656-658; doi:10.2337/diacare.19.6.656
Glycemic Responses to Exercise in IDDM After Simple and Complex Carbohydrate Supplementation Diabetes Care June 1996 19:575-579; doi:10.2337/diacare.19.6.575
Does Suppression of Postprandial Blood Glucose Excursions by the α-Glucosidase Inhibitor Miglitol Improve Insulin Sensitivity
in Diet-Treated Type II Diabetic Patients? Diabetes Care June 1996 19:559-563; doi:10.2337/diacare.19.6.559
Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I
diabetic patients Diabetes Care June 1996 19:580-586; doi:10.2337/diacare.19.6.580
An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDM Diabetes Care June 1996 19:642-647; doi:10.2337/diacare.19.6.642
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
L
Laakso, Markku
Risk Factors Predicting Lower Extremity Amputations in Patients With NIDDM Diabetes Care June 1996 19:607-612; doi:10.2337/diacare.19.6.607
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience Diabetes Care June 1996 19:601-606; doi:10.2337/diacare.19.6.601
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
Lorenz, Rodney A
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
Lupien, Paul J
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
Proinsulin Secretion During the First 3 Years After Diagnosis in Diabetic Patients With and Without Islet Cell Antibodies
Diabetes Care June 1996 19:659-662; doi:10.2337/diacare.19.6.659
Bromocriptine (Ergoset) Reduces Body Weight and Improves Glucose Tolerance in Obese Subjects Diabetes Care June 1996 19:667-670; doi:10.2337/diacare.19.6.667
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDM Diabetes Care June 1996 19:642-647; doi:10.2337/diacare.19.6.642
Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I
diabetic patients Diabetes Care June 1996 19:580-586; doi:10.2337/diacare.19.6.580
Diabetic Foot Infections: Bacteriology and activity of 10 oral antimicrobial agents against bacteria isolated from consecutive
cases Diabetes Care June 1996 19:638-641; doi:10.2337/diacare.19.6.638
Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience Diabetes Care June 1996 19:601-606; doi:10.2337/diacare.19.6.601
Proinsulin Secretion During the First 3 Years After Diagnosis in Diabetic Patients With and Without Islet Cell Antibodies
Diabetes Care June 1996 19:659-662; doi:10.2337/diacare.19.6.659
GAD Antibodies in IDDM in Thailand Diabetes Care June 1996 19:674-675; doi:10.2337/diacare.19.6.674
Peters, Anne L
Quality of Outpatient Care Provided to Diabetic Patients: A health maintenance organization experience Diabetes Care June 1996 19:601-606; doi:10.2337/diacare.19.6.601
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
Erythrocyte Na+-K+-ATPase Activity, Metabolic Control, and Neuropathy in IDDM Patients Diabetes Care June 1996 19:564-568; doi:10.2337/diacare.19.6.564
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDM Diabetes Care June 1996 19:642-647; doi:10.2337/diacare.19.6.642
Glycemic Responses to Exercise in IDDM After Simple and Complex Carbohydrate Supplementation Diabetes Care June 1996 19:575-579; doi:10.2337/diacare.19.6.575
Changing Behavior: Practical lessons from the Diabetes Control and Complications Trial Diabetes Care June 1996 19:648-652; doi:10.2337/diacare.19.6.648
Sen, Chandan K
Increased Resting and Exercise-Induced Oxidative Stress in Young IDDM Men Diabetes Care June 1996 19:569-574; doi:10.2337/diacare.19.6.569
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
Effect of Follow-Up of Women With Gestational Diabetes on the Ratio of IDDM to NIDDM in Pregnancy Diabetes Care June 1996 19:653-655; doi:10.2337/diacare.19.6.653
Glycemic Responses to Exercise in IDDM After Simple and Complex Carbohydrate Supplementation Diabetes Care June 1996 19:575-579; doi:10.2337/diacare.19.6.575
GAD Antibodies in IDDM in Thailand Diabetes Care June 1996 19:674-675; doi:10.2337/diacare.19.6.674
Sundkvist, G
Proinsulin Secretion During the First 3 Years After Diagnosis in Diabetic Patients With and Without Islet Cell Antibodies
Diabetes Care June 1996 19:659-662; doi:10.2337/diacare.19.6.659
An Importance of Carbohydrate Ingestion for the Expression of the Effect of α-Glucosidase Inhibitor in NIDDM Diabetes Care June 1996 19:642-647; doi:10.2337/diacare.19.6.642
Does Suppression of Postprandial Blood Glucose Excursions by the α-Glucosidase Inhibitor Miglitol Improve Insulin Sensitivity
in Diet-Treated Type II Diabetic Patients? Diabetes Care June 1996 19:559-563; doi:10.2337/diacare.19.6.559
The Dense LDL Phenotype: Association with plasma lipoprotein levels, visceral obesity, and hyperinsulinemia in men Diabetes Care June 1996 19:629-637; doi:10.2337/diacare.19.6.629
Erythrocyte Na+-K+-ATPase Activity, Metabolic Control, and Neuropathy in IDDM Patients Diabetes Care June 1996 19:564-568; doi:10.2337/diacare.19.6.564
Effect of Follow-Up of Women With Gestational Diabetes on the Ratio of IDDM to NIDDM in Pregnancy Diabetes Care June 1996 19:653-655; doi:10.2337/diacare.19.6.653
Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I
diabetic patients Diabetes Care June 1996 19:580-586; doi:10.2337/diacare.19.6.580
Diabetic Ketoacidosis in Young Obese Japanese Men Diabetes Care June 1996 19:671; doi:10.2337/diacare.19.6.671a
Yano, Katsuhiko
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program
Diabetes Care June 1996 19:587-590; doi:10.2337/diacare.19.6.587
Glucagonostatic Actions and Reduction of Fasting Hyperglycemia by Exogenous Glucagon-Like Peptide I(7–36) amide in type I
diabetic patients Diabetes Care June 1996 19:580-586; doi:10.2337/diacare.19.6.580